Humedix announced on the 5th that it has signed a business agreement with Exostemtech to develop exosome-based therapeutics and cosmetics.
Exostemtech is a domestic bioventure with technology for mass production, analysis and quality control of exosomes. He said that he has the original technology for an exosome-based protein drug delivery system. Based on stem cell exosomes, it is developing a treatment for degenerative arthritis, a treatment for liver fibrosis, and a treatment for lung fibrosis.